​Collaborations
Yellow4FLAVI collaborates with other scientific projects to advance research and innovation. Discover more about our partnerships and how we work together to enhance research outcomes in the fields of flaviviruses and pandemic preparedness.
_edited.png)
FLAVIVACCINE
Delivering a safe and effective protection against diseases resulting from mosquito-borne flavivirus infections
Flavivaccine will develop a novel prototype vaccine directed against several flaviviruses, define its immunogenicity and efficacy and prepare it for a future clinical evaluation. Instead of directly targeting the virus, this project focuses on the initial infection resulting from contact with mosquitoes.
​
Providing a single solution for multiple diseases, Flavivaccine has the potential to ease the economic and social burden of flaviviruses.
Our project creates a unique interdisciplinary environment, bringing together all the necessary scientific expertise and knowledge to address a critical problem on the rise.
​
CONTAGIO
Empowering global response to outbreaks uniting experts worldwide to swiftly tackle infectious diseases, prioritizing low-resource settings
‘CONTAGIO (COhorts Network To be Activated Globally In Outbreaks) is a consortium of investigators from Europe, North America, Latin America, Asia, and Africa, coordinated by Dr. Thomas Jaenisch at the Universität Heidelberg. An EC HORIZON EUROPE 11 project funded by the European Commission.
CONTAGIO aims to create coordination mechanisms to rapidly react to infectious disease (re-)emergence in low- and middle-income countries. The Consortium builds on the experience acquired through the EC-funded projects ReCoDiD, ORCHESTRA, ZIKAlliance, and IDAMS. CONTAGIO acknowledges the critical connection between infectious diseases and climate change. The open science foreseen in CONTAGIO will create a coordination mechanism and framework for the role of sustainable cohorts in preparedness for (re-)emerging infectious diseases during interepidemic periods, which will be vital for the joint progress towards a better tackling of disease emergence aimed at the protection of citizens in LMICs, Europe and the rest of the world.
​